Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance
Anti-Cancer Drugs, 08/01/2012
Sun YL et al. – The findings suggest a possible strategy to potentially enhance the activity of anticancer drugs using a clinically approved drug with known side effects and drug–drug interactions.



